Literature DB >> 17599052

PRTFDC1, a possible tumor-suppressor gene, is frequently silenced in oral squamous-cell carcinomas by aberrant promoter hypermethylation.

E Suzuki1, I Imoto, A Pimkhaokham, T Nakagawa, N Kamata, K-I Kozaki, T Amagasa, J Inazawa.   

Abstract

Array-based comparative genomic hybridization (array-CGH) has good potential for the high-throughput identification of genetic aberrations in cell genomes. In the course of a program to screen a panel of oral squamous-cell carcinoma (OSCC), cell lines for genomic copy-number aberrations by array-CGH using our in-house arrays, we identified a 3-Mb homozygous deletion at 10p12 in 1 of 18 cell lines (5.6%). Among seven genes located within this region, expression of PRTFDC1 mRNA was not detected in 50% (9/18) or decreased in 5.6% (1/18) of OSCC cell lines, but detected in normal oral epithelia and restored in gene-silenced OSCC cells without its homozygous loss after treatment with 5-aza-2'-deoxycytidine. Among 17 cell lines without a homozygous deletion, the hypermethylation of the PRTFDC1 CpG island, which showed promoter activity, was observed in all nine cell lines with no or reduced PRTFDC1 expression (52.9%). Methylation of this CpG island was also observed in primary OSCC tissues (8/47, 17.0%). In addition, restoration of PRTFDC1 in OSCC cells lacking its expression inhibited cell growth in colony-formation assays, whereas knockdown of PRTFDC1 expression in OSCC cells expressing the gene promoted cell growth. These results suggest that epigenetic silencing of PRTFDC1 by hypermethylation of the CpG island leads to a loss of PRTFDC1 function, which might be involved in squamous cell oral carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599052     DOI: 10.1038/sj.onc.1210589

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

Review 1.  Genetic approaches for the study of PTSD: Advances and challenges.

Authors:  Sunayana B Banerjee; Filomene G Morrison; Kerry J Ressler
Journal:  Neurosci Lett       Date:  2017-02-24       Impact factor: 3.046

2.  A method for detecting significant genomic regions associated with oral squamous cell carcinoma using aCGH.

Authors:  Ki-Yeol Kim; Jin Kim; Hyung Jun Kim; Woong Nam; In-Ho Cha
Journal:  Med Biol Eng Comput       Date:  2010-03-20       Impact factor: 2.602

3.  Role of DNA methylation in head and neck cancer.

Authors:  Semra Demokan; Nejat Dalay
Journal:  Clin Epigenetics       Date:  2011-07-09       Impact factor: 6.551

4.  iCOD: an integrated clinical omics database based on the systems-pathology view of disease.

Authors:  Kazuro Shimokawa; Kaoru Mogushi; Satoshi Shoji; Atsuko Hiraishi; Keisuke Ido; Hiroshi Mizushima; Hiroshi Tanaka
Journal:  BMC Genomics       Date:  2010-12-02       Impact factor: 3.969

5.  Genomic profiling of advanced-stage oral cancers reveals chromosome 11q alterations as markers of poor clinical outcome.

Authors:  Srikant Ambatipudi; Moritz Gerstung; Ravindra Gowda; Prathamesh Pai; Anita M Borges; Alejandro A Schäffer; Niko Beerenwinkel; Manoj B Mahimkar
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

6.  PRTFDC1 is a genetic modifier of HPRT-deficiency in the mouse.

Authors:  Alaine C Keebaugh; Heather A Mitchell; Meriem Gaval-Cruz; Kimberly G Freeman; Gaylen L Edwards; David Weinshenker; James W Thomas
Journal:  PLoS One       Date:  2011-07-27       Impact factor: 3.240

7.  miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2.

Authors:  Yosuke Harazono; Tomoki Muramatsu; Hironori Endo; Narikazu Uzawa; Tatsuyuki Kawano; Kiyoshi Harada; Johji Inazawa; Ken-ichi Kozaki
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

8.  mRNA expression and hypermethylation of tumor suppressor genes apoptosis protease activating factor-1 and death-associated protein kinase in oral squamous cell carcinoma.

Authors:  Chunyan Li; Lin Wang; Jing Su; Ruhui Zhang; Li Fu; Yanmin Zhou
Journal:  Oncol Lett       Date:  2013-05-17       Impact factor: 2.967

9.  Methylation-associated gene silencing of RARB in areca carcinogens induced mouse oral squamous cell carcinoma.

Authors:  Zi-Lun Lai; Yung-An Tsou; Shin-Ru Fan; Ming-Hsui Tsai; Hsiao-Ling Chen; Nai-Wen Chang; Ju-Chien Cheng; Chuan-Mu Chen
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

10.  High-risk oral leukoplakia is associated with aberrant promoter methylation of multiple genes.

Authors:  Masanobu Abe; Satoshi Yamashita; Yoshiyuki Mori; Takahiro Abe; Hideto Saijo; Kazuto Hoshi; Toshikazu Ushijima; Tsuyoshi Takato
Journal:  BMC Cancer       Date:  2016-06-03       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.